Health care costs decline after successful epilepsy surgery

Area of Science:

• Neurosurgery
• Epileptology
• Health Economics

Background:

• Refractory epilepsy treatment increasingly involves surgery, a high-cost intervention.
• Understanding the long-term cost-effectiveness of epilepsy surgery is crucial.
• Limited data exists on healthcare cost changes following epilepsy surgery evaluation and treatment.

Purpose of the Study:

• To evaluate changes in healthcare costs associated with seizure control post-epilepsy surgery.
• To compare costs between patients with persistent seizures and those who become seizure-free.

Main Methods:

• A multicenter observational study of 68 temporal lobe epilepsy (TLE) patients.
• Calculation of healthcare costs for two years pre- and two years post-surgical evaluation.
• Comparison of costs among non-surgical, persistent seizure, and seizure-free post-surgical groups.

Main Results:

• Antiepileptic drugs (AEDs) constituted over half of pre-evaluation care costs.
• Seizure-free patients experienced a 32% cost reduction by two years post-surgery, mainly from reduced AED and inpatient care.
• Patients with persistent seizures, whether operated on or not, showed no significant cost changes.

Conclusions:

• Healthcare costs remain stable for TLE patients with persistent seizures post-evaluation.
• Patients achieving seizure freedom after surgery demonstrate substantial reductions in healthcare utilization.
• Further cost savings are anticipated in seizure-free patients as antiepileptic drug use is minimized.